Posts by: Patricia Inacio

News

The American Lung Association’s Better Breathers Club is now extending its resources and support network to patients with pulmonary fibrosis (PF), among others with chronic lung diseases. Getting a PF diagnosis ... Read more

June 8, 2018June 8, 2018

Double Lung Transplant Better for Pulmonary Fibrosis Patients Younger than 70, Study Shows

News

Double lung transplants are linked to significantly higher survival rates than single lung transplants among pulmonary fibrosis patients younger than 70, a retrospective study shows. The study, “Single versus ... Read more

June 1, 2018June 1, 2018

New Lung-on-a-chip Technology Captures Fibrosis Progression and May Speed Treatment Discovery, Study Reports

Esbriet, News

A new lung-on-a-chip technology models the mechanical changes that occur in the lungs during idiopathic pulmonary fibrosis, possibly allowing for a faster and less expensive screening of potential new ... Read more

May 29, 2018May 29, 2018

#ATS2018 – Esbriet Lowers Risk of Seasonal IPF Flares Leading to Hospitalizations, Phase 3 Data Show

Esbriet, News

Seasonal flares of disease activity that can lead to idiopathic pulmonary fibrosis (IPF) patients being hospitalized, especially in the winter months, appear to be effectively countered by treatment with Esbriet (pirfenidone) compared ... Read more

May 25, 2018May 25, 2018

#ATS2018 — Pamrevlumab Slows Fibrosis Progression, Improves Lung Function in IPF, Phase 2 Trial Shows

News

Investigational Pamrevlumab halts the progression of lung fibrosis and improves lung function in patients with idiopathic pulmonary fibrosis (IPF), new results from the Phase 2 PRAISE trial show. These ... Read more

May 16, 2018May 16, 2018

#ATS2018 – Results of SM04646 Mouse Study for IPF is on ATS Agenda

News

Investigational SM04646 inhibits expression of TGF-beta-stimulated genes known to promote lung fibrosis, a new study shows. The results will be presented in a poster titled “SM04646 Inhibited Wnt Pathway ... Read more

May 11, 2018May 11, 2018

Targeting FOXM1 May Have Therapeutic Potential for IPF, Study Shows

News

The FOXM1 gene is a driver of lung fibroblast proliferation and activation in idiopathic pulmonary fibrosis (IPF), a new study shows. The findings highlight the therapeutic potential of targeting FOXM1 ... Read more

May 3, 2018May 3, 2018

Hastings Foundation Donates $12.5 Million to Lung Disease Research at USC

News

The Hastings Foundation has donated $12.5 million to the University of Southern California (USC) Hastings Center for Pulmonary Research to help advance research and development of new strategies to treat ... Read more

April 20, 2018April 20, 2018

Loss of Elastin in Lungs a Potential Biomarker for Both IPF and COPD, Study Suggests

News

Idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) may share a common disease mechanism — degradation of elastin in the lungs — suggesting its potential as a ... Read more

April 4, 2018April 4, 2018

Clusterin Protein in Lungs Can Both Protect Against and Promote Fibrosis, Study Shows

News

Cells’ attempts to limit fibroblast proliferation by lowering the levels of a protein called clusterin in lung fibroblasts of pulmonary fibrosis patients were found to be an insufficient strategy ... Read more

Posts by: Patricia Inacio

Patricia Inacio

American Lung Association’s Better Breathers Club Welcomes PF Patients and Caregivers

Double Lung Transplant Better for Pulmonary Fibrosis Patients Younger than 70, Study Shows

New Lung-on-a-chip Technology Captures Fibrosis Progression and May Speed Treatment Discovery, Study Reports

#ATS2018 – Esbriet Lowers Risk of Seasonal IPF Flares Leading to Hospitalizations, Phase 3 Data Show

#ATS2018 — Pamrevlumab Slows Fibrosis Progression, Improves Lung Function in IPF, Phase 2 Trial Shows

#ATS2018 – Results of SM04646 Mouse Study for IPF is on ATS Agenda

Targeting FOXM1 May Have Therapeutic Potential for IPF, Study Shows

Hastings Foundation Donates $12.5 Million to Lung Disease Research at USC

Loss of Elastin in Lungs a Potential Biomarker for Both IPF and COPD, Study Suggests

Clusterin Protein in Lungs Can Both Protect Against and Promote Fibrosis, Study Shows

Pin It on Pinterest